242 related articles for article (PubMed ID: 15720805)
1. Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells.
Faltus T; Yuan J; Zimmer B; Krämer A; Loibl S; Kaufmann M; Strebhardt K
Neoplasia; 2004; 6(6):786-95. PubMed ID: 15720805
[TBL] [Abstract][Full Text] [Related]
2. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
Menendez JA; Vellon L; Lupu R
Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086
[TBL] [Abstract][Full Text] [Related]
3. Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines.
Choudhury A; Charo J; Parapuram SK; Hunt RC; Hunt DM; Seliger B; Kiessling R
Int J Cancer; 2004 Jan; 108(1):71-7. PubMed ID: 14618618
[TBL] [Abstract][Full Text] [Related]
4. [Effects of Her-2/neu siRNA-mediated gene silencing on cell cycle and apoptosis of lung adenocarcinoma cells].
Ren SH; Wang JW; Zhang L
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(22):1530-4. PubMed ID: 16179111
[TBL] [Abstract][Full Text] [Related]
5. ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro.
Jiang Q; Zhang H; Zhang P
J Exp Clin Cancer Res; 2011 May; 30(1):60. PubMed ID: 21595884
[TBL] [Abstract][Full Text] [Related]
6. Effect of siRNA targeting HER2/neu on the proliferation and viability of prostate cancer PC-3M cells.
Liu CY; Xu PC; Chen DG; Fan XH; Li MQ; Yang X; Xu YP
Genet Mol Res; 2015 Dec; 14(4):17145-53. PubMed ID: 26681061
[TBL] [Abstract][Full Text] [Related]
7. Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway.
Way TD; Kao MC; Lin JK
J Biol Chem; 2004 Feb; 279(6):4479-89. PubMed ID: 14602723
[TBL] [Abstract][Full Text] [Related]
8. [The effect of siRNA-Her2/neu on the drug sensitivity of Her2/neu-overexpressing lung adenocarcinoma cell line].
Ren SH; Zhang L; Wang JW; Tian HM; Qü P; Zhang W
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jan; 29(1):35-8. PubMed ID: 16638299
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of breast and ovarian tumor growth through multiple signaling pathways by using retrovirus-mediated small interfering RNA against Her-2/neu gene expression.
Yang G; Cai KQ; Thompson-Lanza JA; Bast RC; Liu J
J Biol Chem; 2004 Feb; 279(6):4339-45. PubMed ID: 14625284
[TBL] [Abstract][Full Text] [Related]
10. Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells.
Spänkuch-Schmitt B; Bereiter-Hahn J; Kaufmann M; Strebhardt K
J Natl Cancer Inst; 2002 Dec; 94(24):1863-77. PubMed ID: 12488480
[TBL] [Abstract][Full Text] [Related]
11. Effects of RNA interference-mediated silencing of toll-like receptor 4 gene on proliferation and apoptosis of human breast cancer MCF-7 and MDA-MB-231 cells: An in vitro study.
Gao XL; Yang JJ; Wang SJ; Chen Y; Wang B; Cheng EJ; Gong JN; Dong YT; Liu D; Wang XL; Huang YQ; An DD
J Cell Physiol; 2018 Jan; 234(1):433-442. PubMed ID: 29932226
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of bach1 siRNA on human breast adenocarcinoma cell line.
Aletaha M; Mansoori B; Mohammadi A; Fazeli M; Baradaran B
Biomed Pharmacother; 2017 Apr; 88():34-42. PubMed ID: 28092843
[TBL] [Abstract][Full Text] [Related]
13. Silencing of ANXA3 expression by RNA interference inhibits the proliferation and invasion of breast cancer cells.
Zhou T; Li Y; Yang L; Liu L; Ju Y; Li C
Oncol Rep; 2017 Jan; 37(1):388-398. PubMed ID: 27878264
[TBL] [Abstract][Full Text] [Related]
14. [The effect of HER2/neu overexpression on p53 gene expression, cell proliferation and sensitivity to gamma-irradiation via the PI3K/Akt pathway in breast cancer cell MCF7].
Zheng L; Ren JQ; Chen Q; Zhang HP; Zhu HG
Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):594-7. PubMed ID: 15634518
[TBL] [Abstract][Full Text] [Related]
15. HER2/neu increases the expression of Wilms' Tumor 1 (WT1) protein to stimulate S-phase proliferation and inhibit apoptosis in breast cancer cells.
Tuna M; Chavez-Reyes A; Tari AM
Oncogene; 2005 Feb; 24(9):1648-52. PubMed ID: 15674342
[TBL] [Abstract][Full Text] [Related]
16. Jun amino-terminal kinase 1 activation promotes cell survival in ErbB2-positive breast cancer.
Han JS; Crowe DL
Anticancer Res; 2010 Sep; 30(9):3407-12. PubMed ID: 20944115
[TBL] [Abstract][Full Text] [Related]
17. SV40 T/t-common polypeptide specifically induces apoptosis in human cancer cells that overexpress HER2/neu.
Wen CC; Cheng SA; Hsuen SP; Huang YL; Kuo ZK; Lee HF; Kuo CH; Du JL; Wang WB
Cancer Res; 2006 Jun; 66(11):5847-57. PubMed ID: 16740724
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells.
Menendez JA; Vellon L; Mehmi I; Oza BP; Ropero S; Colomer R; Lupu R
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10715-20. PubMed ID: 15235125
[TBL] [Abstract][Full Text] [Related]
19. [Impact of siRNA-mediated down-regulation of CD147 on human breast cancer cells].
Li Z; Li D; Li J; Huang P; Qin H
Zhonghua Bing Li Xue Za Zhi; 2015 Oct; 44(10):734-8. PubMed ID: 26702532
[TBL] [Abstract][Full Text] [Related]
20. Palmitate-induced ER stress increases trastuzumab sensitivity in HER2/neu-positive breast cancer cells.
Baumann J; Wong J; Sun Y; Conklin DS
BMC Cancer; 2016 Jul; 16():551. PubMed ID: 27464732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
